These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10976431)

  • 1. [Kinins: their nature and their potential role in the cardiovascular effects of angiotensin-converting enzyme inhibitors].
    Adam A; Blais C; Loute G
    Nephrologie; 2000; 21(4):163-72. PubMed ID: 10976431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for bradykinin in the therapeutic and side effects of angiotensin-converting enzyme inhibitors?
    Marceau F
    Can J Cardiol; 1997 Feb; 13(2):187-94. PubMed ID: 9070170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crucial suppressive role of renal kallikrein-kinin system in development of salt-sensitive hypertension.
    Katori M; Majima M; Hayashi I
    Biol Res; 1998; 31(3):143-9. PubMed ID: 9830501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular properties of the kallikrein-kinin system.
    Sharma JN; Sharma J
    Curr Med Res Opin; 2002; 18(1):10-7. PubMed ID: 11999140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical insights into the beneficial and protective actions of the kallikrein-kinin system.
    Regoli D; Gobeil F
    Vascul Pharmacol; 2015 Jan; 64():1-10. PubMed ID: 25579779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kallikrein-kinin system as a regulator of cardiovascular and renal function.
    Rhaleb NE; Yang XP; Carretero OA
    Compr Physiol; 2011 Apr; 1(2):971-93. PubMed ID: 23737209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II inhibition attenuates postexercise proteinuria in rats.
    Gündüz F; Kuru O; Sentürk UK
    Int J Sports Med; 2005 Nov; 26(9):710-3. PubMed ID: 16237614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kallikrein-kinin system: current and future pharmacological targets.
    Moreau ME; Garbacki N; Molinaro G; Brown NJ; Marceau F; Adam A
    J Pharmacol Sci; 2005 Sep; 99(1):6-38. PubMed ID: 16177542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular and functional aspects of the renal kallikrein system in health and disease.
    Vio CP; Olavarría V; González C; Nazal L; Córdova M; Balestrini C
    Biol Res; 1998; 31(3):305-22. PubMed ID: 9830518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system.
    Marcondes S; Antunes E
    Curr Med Chem Cardiovasc Hematol Agents; 2005 Jan; 3(1):33-44. PubMed ID: 15638742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of the intrarenal kallikrein-kinin system: proposed role in renal development.
    el-Dahr SS
    Microsc Res Tech; 1997 Nov; 39(3):222-32. PubMed ID: 9372496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the renal kallikrein-kinin system in the development of salt-sensitive hypertension.
    Katori M; Majima M; Hayashi I; Fujita T; Yamanaka M
    Biol Chem; 2001 Jan; 382(1):61-4. PubMed ID: 11258674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial mechanisms in vasomotor effects of ACE inhibitors].
    Busse R; Hecker M
    Z Kardiol; 1994; 83 Suppl 4():1-6. PubMed ID: 7856274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardioactive hormones: bradykinin].
    Dendorfer A; Simon M; Dominiak P
    Z Kardiol; 1996; 85 Suppl 6():211-8. PubMed ID: 9064968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the kinin system mediate in cardiovascular abnormalities? An overview.
    Sharma JN
    J Clin Pharmacol; 2003 Nov; 43(11):1187-95. PubMed ID: 14551172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The kallikrein-kinin system: its significance in circulatory failure and the effect of angiotensin I-converting enzyme inhibitors].
    Ol'binskaia LI; Golokolenova GM; Kuznetsov VA
    Ter Arkh; 1994; 66(9):88-92. PubMed ID: 7992226
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation.
    Moreau ME; Dubreuil P; Molinaro G; Chagnon M; Müller-Esterl W; Lepage Y; Marceau F; Adam A
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1065-74. PubMed ID: 16166273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of disease: the tissue kallikrein-kinin system in hypertension and vascular remodeling.
    Madeddu P; Emanueli C; El-Dahr S
    Nat Clin Pract Nephrol; 2007 Apr; 3(4):208-21. PubMed ID: 17389890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.